Your browser doesn't support javascript.
loading
Expert consensus statement on Danshen Chuanxiongqin Injection in clinical practice / 中国中药杂志
China Journal of Chinese Materia Medica ; (24): 2937-2942, 2019.
Article in Chinese | WPRIM | ID: wpr-773207
ABSTRACT
Danshen Chuanxiongqin Injection is a commonly used medicine in cerebral infarction and coronary heart disease,which is recommended by many disease guidelines/consensus for cardiovascular and cerebrovascular diseases. However,there are irrational drug using in clinic,which affects the efficacy and brings safety risks. Based on clinical research evidence and expert experience,recommendations/consensus suggestion are determined through the nominal group method. The expert consensus recommends the indications,intervention time for treatment,route of drug administration,usage and dosage,course of treatment and introduces the safety in clinical application,which could provide reference for clinical use of Danshen Chuanxiongqin Injection.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Drugs, Chinese Herbal / Cerebral Infarction / Consensus / Therapeutic Uses / Drug Therapy / Injections Type of study: Practice guideline Limits: Humans Language: Chinese Journal: China Journal of Chinese Materia Medica Year: 2019 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Drugs, Chinese Herbal / Cerebral Infarction / Consensus / Therapeutic Uses / Drug Therapy / Injections Type of study: Practice guideline Limits: Humans Language: Chinese Journal: China Journal of Chinese Materia Medica Year: 2019 Type: Article